R&D | May 12, 2026
Laser-based framework to precisely control liquid droplets
Study published BY IIT Kanpur researchers could advance drug delivery and biomedical technologies
Study published BY IIT Kanpur researchers could advance drug delivery and biomedical technologies
The company highlighted a series of strategic moves during the year, including the acquisition of WOKADINE, marking its entry into the Rs. 648 Cr Povidone Iodine market
75 bikers participated in the rally organised by Thalassemia and Sickle Cell Society to promote early screening and voluntary blood donation
Women’s wellness initiative promoted preventive healthcare, fitness, and self-care awareness across the Mira Bhayandar community
Pharma major to engage with institutional investors through group meetings in Mumbai and Singapore during May 2026
The CDMO segment saw a 22% decline in Q4 due to a strong base in the prior year
Proposed amalgamation now awaits NCLT approval; shareholders to receive 51 Torrent Pharma shares for every 100 JB Pharma shares held
Strong export-led growth and improved profitability as the company focuses on CNS drug development and global regulatory footprint
The six-part webinar series aims to enhance awareness, diagnosis, and management of autoimmune diseases
The once-daily oral therapy is the first and only tyrosine kinase 2 (TYK2) inhibitor approved in the European Union for this indication, marking a significant expansion of its immunology portfolio
Subscribe To Our Newsletter & Stay Updated
